WXFL10030390
- Generic Name
- WXFL10030390
A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Target Recruit Count
- 38
- Registration Number
- NCT06132932
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, Shanghai, China
A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
Phase 2
Recruiting
- Conditions
- Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
- Interventions
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT06124963
- Locations
- 🇨🇳
The Obstetrics & Gynecology Hospital of Fudan University (Shanghai Red House Ob & Gyn Hospital), Shanghai, Shanghai, China
A Study of WX390 in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT06117540
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06117566
- Locations
- 🇨🇳
the first affiliated hospital of Jilin university, Changchun, Jilin, China
A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Target Recruit Count
- 82
- Registration Number
- NCT03730142
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath